We are live on ! Find out more
PRTG

Post Resch Tallon Group Portfolio holdings

AUM $145M
1-Year Est. Return 25.19%
This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+25.19%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$113M
AUM Growth
+$9.22M
Cap. Flow
+$3.16M
Cap. Flow %
2.8%
Top 10 Hldgs %
45.46%
Holding
111
New
11
Increased
39
Reduced
26
Closed
2

Sector Composition

Rank Sector Weight
1 Technology 10.28%
2 Healthcare 6.53%
3 Real Estate 6.43%
4 Financials 3.92%
5 Communication Services 2.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCX icon
101
BlackRock Resources & Commodities Strategy Trust
BCX
$896M
$138K 0.12%
13,525
F icon
102
Ford
F
$60.9B
$127K 0.11%
10,578
VVR icon
103
Invesco Senior Income Trust
VVR
$456M
$124K 0.11%
35,894
+6,186
+21% +$22.6K
JPC icon
104
Nuveen Preferred & Income Opportunities Fund
JPC
$2.88B
$119K 0.11%
14,560
MYN icon
105
BlackRock MuniYield New York Quality Fund
MYN
$376M
$106K 0.09%
10,650
AGEN
106
Agenus
AGEN
$276M
$77K 0.07%
+20,000
New +$100K
QTRX icon
107
Quanterix
QTRX
$159M
$65.6K 0.06%
12,075
-100
-0.8% -$532
CDLX icon
108
Cardlytics
CDLX
$22.2M
$48.6K 0.04%
2,000
CRDF icon
109
Cardiff Oncology
CRDF
$63M
$46.4K 0.04%
+22,538
New +$62.3K
DIS icon
110
Walt Disney
DIS
$171B
-1,743
Closed -$216K
DIVS icon
111
Guinness Atkinson Dividend Builder ETF
DIVS
$40.8M
-7,350
Closed -$226K

Similar funds

Post Resch Tallon Group's Q3 2025 Portfolio in Review

As of Q3 2025, Post Resch Tallon Group held 111 positions worth $113M, up 8.9% from $104M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Post Resch Tallon Group's Q3 2025 filing shows 11 new, 39 increased, 26 reduced and 2 closed positions. Its largest new stake was Syndax Pharmaceuticals: 25,800 shares worth $397K. The largest sale was Guinness Atkinson Dividend Builder ETF, an estimated $226K.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Healthcare and Real Estate.

  • Post Resch Tallon Group's largest Q3 2025 buy was Syndax Pharmaceuticals: 25,800 shares worth $397K.
  • Post Resch Tallon Group added most to Pacer US Large Cap Cash Cows Growth Leaders ETF in Q3 2025, an estimated $494K increase.
  • Post Resch Tallon Group's biggest Q3 2025 reduction was Palantir, cutting an estimated $219K.
  • Post Resch Tallon Group fully exited Guinness Atkinson Dividend Builder ETF in Q3 2025, selling an estimated $226K.
  • Post Resch Tallon Group's ten largest holdings make up 45% of its $113M portfolio in Q3 2025.
  • Post Resch Tallon Group opened 11 new positions and closed 2 in Q3 2025.
  • Post Resch Tallon Group's portfolio value rose 8.9% quarter-over-quarter to $113M.

Based on Post Resch Tallon Group's 13F filing for Q3 2025, filed 5 Nov 2025.